Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays

Publisher： John Wiley & Sons Inc

ISSN： 1750-2640

Source： Influenza and Other Respiratory Viruses, Vol.12, Iss.2, 2018-03, pp. : 250-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardisation of inactivated influenza vaccines—Learning from history

By  

Influenza and Other Respiratory Viruses, Vol. 12, Iss. 2, 2018-03 ,pp. : 195-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination

By  

Influenza and Other Respiratory Viruses, Vol. 12, Iss. 2, 2018-03 ,pp. : 202-210

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs

By  

Influenza and Other Respiratory Viruses, Vol. 9, Iss. 5, 2015-09 ,pp. : 263-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the three waves of avian influenza A(H7N9) virus circulation since live poultry markets were permanently closed in the main urban areas in Zhejiang Province, July 2014‐June 2017

By  

Influenza and Other Respiratory Viruses, Vol. 12, Iss. 2, 2018-03 ,pp. : 259-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mortality burden from seasonal influenza and 2009 H1N1 pandemic influenza in Beijing, China, 2007‐2013

By  

Influenza and Other Respiratory Viruses, Vol. 12, Iss. 1, 2018-01 ,pp. : 88-97

John Wiley & Sons Inc

Access to resources Recommend Favorite